SURESH GARG

      DIN: 01216073

      For latest information about the director, visit MCA.

      SURESH GARG is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 01216073. SURESH GARG is/has been associated with 22 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      ZEON NUTRITION LLP Designated Partner 05-Aug-2016
      ZEON WELLNESS LLP Designated Partner 24-Jul-2017
      BASCO BUSINESS SERVICES LLP Designated Partner 09-Feb-2022
      ZEORIC NUTRITION LLP Designated Partner 22-Aug-2022
      RS NUTRITION LLP Designated Partner 28-Nov-2023
      GG ACTIVE LIVING LLP Designated Partner 06-Dec-2023
      ZEON GLOBAL NUTRITIONS PRIVATE LIMITED Director 10-Apr-2018
      ZEON LIFESCIENCES LIMITED Managing Director 13-Mar-1987
      ZEON HEALTHCARE PRIVATE LIMITED Director 30-Sep-2011
      SCOT DERMA PRIVATE LIMITED Director 05-Sep-2022
      BIOTIC HEALTHCARE PRIVATE LIMITED Director 05-Sep-2022
      HEALTHY INDIA INFRASTRUCTURE PRIVATE LIMITED Director 10-Jun-2010
      BIOCORP LIFE SCIENCES PRIVATE LIMITED Director 05-Sep-2022
      HIMACHAL CHAMBER OF COMMERCE AND INDUSTRY Director 01-Jul-2005

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      MAHAAN FOODS LIMITED Additional Director 05-Sep-2007 29-Sep-2007
      MAHAAN FOODS LIMITED Director 29-Sep-2007 25-Oct-2010
      HEALTHY INDIA NUTRITIONAL PRODUCTS PRIVATE LIMITED Additional Director 30-Apr-2011 30-Sep-2011
      HEALTHY INDIA NUTRITIONAL PRODUCTS PRIVATE LIMITED Director 30-Sep-2011 13-Jan-2017
      ZEON LIFESCIENCES LIMITED Managing Director 13-Mar-1987 30-Jun-2022
      ZEON WELLNESS PRIVATE LIMITED Director 18-Dec-1992 23-Jul-2017
      ZEON HEALTHCARE PRIVATE LIMITED Additional Director 30-Apr-2011 30-Sep-2011
      NUTODAY PRIVATE LIMITED Additional Director 30-Aug-2021 31-Jan-2022

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales